open access

Vol 7, No 2 (2011)
REVIEW ARTICLES
Published online: 2011-06-22
Get Citation

Maintenance treatment of patients with follicular lymphoma

Piotr Smolewski, Tadeusz Robak
Onkol. Prak. Klin 2011;7(2):84-88.

open access

Vol 7, No 2 (2011)
REVIEW ARTICLES
Published online: 2011-06-22

Abstract

Follicular lymphoma (FL) is a relatively frequent malignant disease, comprising approximately 20% of lymphoid malignancies. Clinically it is defined as an indolent disease. Despite the recent progress in treatment of hematological tumors, FL still remains an incurable disease. In patients with progressive disease, a standard of first line treatment are COP (cyclophosphamide, vincristine, prednizon) or CHOP (cyclophosphamide, doksorubicine, vincristine, prednizon) regimens, administrated in combination with anti-CD20 antigen antibody, rituximab (RIT). Most recently, the role of RIT maintenance in prolongation of disease progression free survival and, potentially, overall survival of FL patients has been underlined.
Onkol. Prak. Klin. 2011; 7, 2: 84–88

Abstract

Follicular lymphoma (FL) is a relatively frequent malignant disease, comprising approximately 20% of lymphoid malignancies. Clinically it is defined as an indolent disease. Despite the recent progress in treatment of hematological tumors, FL still remains an incurable disease. In patients with progressive disease, a standard of first line treatment are COP (cyclophosphamide, vincristine, prednizon) or CHOP (cyclophosphamide, doksorubicine, vincristine, prednizon) regimens, administrated in combination with anti-CD20 antigen antibody, rituximab (RIT). Most recently, the role of RIT maintenance in prolongation of disease progression free survival and, potentially, overall survival of FL patients has been underlined.
Onkol. Prak. Klin. 2011; 7, 2: 84–88
Get Citation

Keywords

follicular lymphoma; immunochemotherapy; maintenance treatment

About this article
Title

Maintenance treatment of patients with follicular lymphoma

Journal

Oncology in Clinical Practice

Issue

Vol 7, No 2 (2011)

Pages

84-88

Published online

2011-06-22

Bibliographic record

Onkol. Prak. Klin 2011;7(2):84-88.

Keywords

follicular lymphoma
immunochemotherapy
maintenance treatment

Authors

Piotr Smolewski
Tadeusz Robak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl